Results 291 to 300 of about 2,569,145 (337)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer

open access: yesMolecular Oncology, EarlyView.
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta   +10 more
wiley   +1 more source

Outcome Assessment in Children and Adolescents With Chronic Pain: An International Clinical Practice Survey. [PDF]

open access: yesEur J Pain
Miró J   +20 more
europepmc   +1 more source

Microcephaly with Simplified Gyral Pattern in Children: Quantitative Morphometric Assessment on Brain MRI and Correlation with Clinical Outcome

open access: gold
Stefanie Chambers   +6 more
openalex   +1 more source

Development of a core outcome set for the assessment of spasticity in adults: a study protocol. [PDF]

open access: yesTrials
Hill B   +6 more
europepmc   +1 more source

Patient experience and clinical outcome assessment validity in amyotrophic lateral sclerosis: a targeted literature review

open access: gold
Sarah E. Curtis   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy